Stada And Alvotech Eye Potential EU Ustekinumab Nod This Year

A Frontrunner Filing For A Stelara Biosimilar Has Been Accepted For Review By The EMA

 
• By David Wallace
  
EMA
The EMA is examining Alvotech and Stada’s ustekinumab filing
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products